`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`APPLE INC.
`Petitioner
`v.
`FINTIV, INC.
`Patent Owner
`
`____________
`
`Case No. IPR2020-00019
`U.S. Patent 8,843,125 B2
`Title: SYSTEM AND METHOD FOR MANAGING MOBILE WALLET AND
`ITS RELATED CREDENTIALS
`_________________________________________________________________
`
`APPLE INC.’S PRELIMINARY REPLY
`_________________________________________________________________
`
`
`
`TABLE OF CONTENTS
`
`I.
`
`II.
`
`The District Court’s Trial Date Should Not Control Institution ............. 1
`Congress Established a 1-Year Filing Window. .................................. 1
`Trial-Based Institution Encourages Forum Shopping .......................... 2
`Initial Trial Dates are Frequently Continued ....................................... 3
`The NHK Factors Favor Institution ............................................................ 5
`Potential for a district court stay .......................................................... 6
`Proximity of the court’s trial date ........................................................ 7
`Investment in the parallel proceeding by the court and the
`parties ................................................................................................... 7
`Overlap between issues in the petition and the parallel
`proceeding ............................................................................................ 9
`Whether the petitioner and the defendant are the same party ............ 10
`Other circumstances impacting the Board’s exercise of
`discretion ............................................................................................ 10
`
`i
`
`
`
`LISTING OF EXHIBITS
`
`Exhibit
`
`Description
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`1014
`
`1015
`
`1016
`
`U.S. Patent No. 8,843,125 to Kwon et al.
`
`File History of U.S. Patent No. 8,843,125 to Kwon et al.
`
`Declaration of Dr. Clifford Neuman
`
`U.S. Patent Publication No. 2010/0138518 to Aiglstorfer et al.
`
`U.S. Patent Publication No. 2010/0190437 to Buhot
`
`eWallet: Users Guide and Reference: Version 5.0, Ilium Software
`(Nov. 2007) (available at https://web.archive.org/web/
`20071110033509/http:/www.iliumsoft.com/gh/download/
`doc/eWallet.pdf)
`
`Excerpt from the File History of U.S. Patent No. 8,646,056 to
`Poplett
`
`CN101459902A to Wang et al.
`
`English translation of CN101459902A to Wang et al. and
`associated translator declaration
`
`[Reserved]
`
`U.S. Patent No. 6,832,373 to O’Neill
`
`Provisional U.S. Patent App. No. 61/428,846
`
`Provisional U.S. Patent App. No. 61/428,851
`
`Provisional U.S. Patent App. No. 61/428,852
`
`Provisional App. No. 61/428,853
`
`Apple’s Opening Claim Construction Brief from Fintiv, Inc. v.
`Apple Inc., Case No. 6:18-cv-00372 (W.D. Tex.), Dkt. 71.
`
`ii
`
`
`
`Exhibit
`
`Description
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`1028
`
`Plaintiff Fintiv, Inc.’s Opening Claim Construction Brief from
`Fintiv, Inc. v. Apple Inc., Case No. 6:18-cv-00372 (W.D. Tex.),
`Dkt. 72.
`
`Apple’s Responsive Claim Construction Brief from Fintiv, Inc. v.
`Apple Inc., Case No. 6:18-cv-00372 (W.D. Tex.), Dkt. 74.
`
`Plaintiff Fintiv, Inc.’s Responsive Claim Construction Brief from
`Fintiv, Inc. v. Apple Inc., Case No. 6:18-cv-00372 (W.D. Tex.),
`Dkt. 75.
`
`Apple’s Reply Claim Construction Brief from Fintiv, Inc. v. Apple
`Inc., Case No. 6:18-cv-00372 (W.D. Tex.), Dkt. 76.
`
`Plaintiff Fintiv, Inc.’s Reply Claim Construction Brief from Fintiv,
`Inc. v. Apple Inc., Case No. 6:18-cv-00372 (W.D. Tex.), Dkt. 77.
`
`Agreed Scheduling Order Subsequent to Case Management
`Conference from Fintiv, Inc. v. Apple Inc., Case No. 6:18-cv-00372
`(W.D. Tex.), Dkt. 38.
`
`Swick et al., “The X Toolkit: More Bricks for Building User-
`Interfaces−or−Widgets For Hire,” published in USENIX Winter
`1988.
`
`Excerpt from Underdahl, “iPAQ™ for Dummies®” (2004) and
`associated Library of Congress Certification
`
`Excerpt from Peacock, “Windows® CE, Clear & Simple” (1999)
`and Associated Library of Congress Certification
`
`Excerpt from McPherson, “How to Do Everything with Your
`Pocket PC” (2nd Ed. 2002) and Associated Library of Congress
`Certification
`
`Claim Construction Order from Fintiv, Inc. v. Apple Inc., Case No.
`6:18-cv-00372 (W.D. Tex.), Dkt. 86.
`
`U.S. Patent Publication No. 2012/0095852 to Bauer et al.
`
`iii
`
`
`
`Exhibit
`
`Description
`
`1029
`
`1030
`
`1031
`
`1032
`
`1033
`
`1034
`
`1035
`
`1036
`
`1037
`
`1038
`
`1039
`
`1040
`
`ISO/IEC 7816-4 Standard, First Edition (Sept. 1, 1995) as
`submitted on May 9, 2006 in an IDS for U.S. Pat. App. 10/471,883
`
`ISO/IEC 7816-4 Standard, First Edition (Sept. 1, 1995) and Second
`Edition (Jan. 15, 2005) as submitted on April 6, 2009 in an IDS for
`U.S. Pat. App. 12/376,360
`
`ISO/IEC 14443-4 Standard, First Edition (Feb. 2, 2001)
`
`ISO/IEC 14443-4 Standard (July 13, 2000) as submitted on Feb. 1,
`2005 in an IDS for U.S. Pat. App. 10/937,084
`
`Cover pleading for Fintiv’s Initial Disclosure of Asserted Claims,
`Accused Instrumentalities, and Infringement Contentions from
`Fintiv, Inc. v. Apple Inc., Case No. 6:18-cv-00372 (W.D. Tex.)
`(dated May 20, 2019)
`
`Excerpts from Fintiv’s First Amended and Supplemental
`Responses and Objections to Apple’s First Set of Interrogatories
`(no pre-suit notice) from Fintiv, Inc. v. Apple Inc., Case No. 6:18-
`cv-00372 (W.D. Tex.) (dated February 24, 2020)
`
`Docket Navigator nationwide trial date continuance statistics
`(including table of underlying cases)
`
`Docket Navigator nationwide time-to-trial statistics for patent cases
`
`Docket Navigator WDTX time-to-trial statistics for patent cases
`
`Western District of Texas Order re COVID-19, dated March 13,
`2020
`
`Email correspondence between counsel for Apple and Fintiv re:
`depositions and case schedule
`
`Collection of deposition notices, subpoena excerpts, and 30(b)(6)
`topics from Fintiv, Inc. v. Apple Inc., Case No. 6:18-cv-00372
`(W.D. Tex.)
`
`iv
`
`
`
`Exhibit
`
`Description
`
`1041
`
`1042
`
`1043
`
`1044
`
`1045
`
`1046
`
`1047
`
`1048
`
`Email correspondence between counsel for Apple and Fintiv re:
`source code inspection
`
`Shelter-in-Place Orders for San Francisco and Santa Clara
`Counties, dated March 16, 2020
`
`Email from Fintiv counsel re: document production, dated March
`10, 2020
`
`Email correspondence from Fintiv re: refiling IPR petition, dated
`November 21, 2019
`
`Cover document from Apple’s Final Invalidity Contentions from
`Fintiv, Inc. v. Apple Inc., Case No. 6:18-cv-00372 (W.D. Tex.)
`(dated January 17, 2020)
`
`Fintiv’s Second Amended Complaint from Fintiv, Inc. v. Apple
`Inc., Case No. 6:18-cv-00372 (W.D. Tex.), Dkt. 92 (dated January
`30, 2020)
`
`Apple’s Motion to Dismiss Fintiv’s Second Amended Complaint
`from Fintiv, Inc. v. Apple Inc., Case No. 6:18-cv-00372 (W.D.
`Tex.), Dkt. 93 (dated February 12, 2020)
`
`Apple Press release announcing Apple Pay
`(https://www.apple.com/newsroom/2014/09/09Apple-Announces-
`Apple-Pay/), dated September 9, 2014
`
`v
`
`
`
`As authorized in Paper 11, Apple respectfully submits this brief addressing
`
`whether the Board should exercise its discretion under § 314(a) to institute Apple’s
`
`IPR. The answer is a resounding yes. As discussed herein and in Sand Revolution
`
`v. Continental, denying institution under § 314 would be contrary to Congressional
`
`intent, encourage forum shopping, place undue emphasis on an uncertain trial date,
`
`and set unrealistic timing requirements to prepare and file IPRs. See IPR2019-
`
`01393, Paper 15 (March 6, 2020). Such a result would be inequitable on the facts
`
`of this case and is not supported by NHK or sound policy. See NHK Spring Co. v.
`
`Intri-plex Techs., Inc., IPR2018-00752, Paper 8 (PTAB Sept. 12, 2018).
`
`I.
`
`The District Court’s Trial Date Should Not Control Institution
`Congress Established a 1-Year Filing Window
`After thorough consideration, Congress established a 1-year window for
`
`filing IPR petitions. Notably, § 315(b) originally contained only a 6-month filing
`
`window which was amended to 1-year prior to passage of the AIA to “afford
`
`defendants a reasonable opportunity to identify and understand the patent claims
`
`that are relevant to the litigation” before filing an IPR. 157 Cong. Rec. S5429
`
`(daily ed. Sept. 8, 2011) (Sen. Kyl). Especially where, as here, the petitioner had
`
`no pre-suit notice (Ex. 1034) and Fintiv did not identify the asserted claims until 5-
`
`months after the Complaint was filed (Ex. 1033), a 1-year filing window is
`
`appropriate. Reducing the Congressionally-proscribed 1-year period undermines
`
`1
`
`
`
`the AIA’s objectives of improving patent quality and reducing costs by forcing
`
`parties to (1) engage in the full course of civil litigation or (2) participate in IPR
`
`proceedings without an adequate opportunity to prepare an IPR petition.
`
`In addition to providing district court defendants a year to file IPRs,
`
`Congress keyed the filing period prospectively from service of the complaint, not
`
`retrospectively from the trial date. 35 U.S.C. 314(b). This is for good reason: the
`
`service date of a Complaint is a fixed marker known ex ante. By contrast, trial
`
`dates vary from court to court (and even by judge) and may not even be set when a
`
`Petitioner files an IPR (as was the case here). They are also often moving targets.
`
`Elevating the uncertain timing of trial over the fixed statutory filing window as a
`
`threshold for institution contravenes Congressional intent.
`
`Trial-Based Institution Encourages Forum Shopping
`Petitioners should not be prejudiced in seeking IPR based on a forum
`
`selected by the patent owner. Denying an IPR solely (or in significant part) based
`
`on a trial date insulates patents against IPR in fast trial venues, limits PTAB access
`
`to only defendants sued in slower jurisdictions, and encourages forum shopping. If
`
`the possibility of trial prior to a FWD acts as a de-facto bar on institution, the
`
`PTAB’s doors will be unfairly closed to all defendants in any jurisdiction that sets
`
`an early trial date. There is no basis in statute or the rules for such disparate
`
`venue-based treatment. Congress offered IPRs as a litigation alternative to
`
`2
`
`
`
`petitioning parties; it did not afford patent owners an option to self-select out of
`
`IPR proceedings. The AIA should provide petitioners a fair shake before the
`
`PTAB regardless of the district court chosen by the patent owner (especially
`
`where, as here, Apple disputes the propriety of Fintiv’s selected forum under
`
`§ 1404(a)). See Fed. Cir. Misc. Case No. 20-104 (pending petition for en banc
`
`rehearing re transfer).
`
`Moreover, making the trial date a threshold consideration before institution
`
`ignores the common scenario, contemplated by Congress, of obtaining a district
`
`court stay based on institution. See, e.g., IOENGINE, LLC v. PayPal Holdings,
`
`Inc., 2019 U.S. Dist. LEXIS 141545, at *9-10 (D. Del. Aug. 21, 2019) (J. Bryson);
`
`157 Cong. Rec. S1363 (daily ed. Mar. 8, 2011) (Sen. Schumer); H. Rep. No. 112-
`
`98, Part I, at 48 (2011). Denying institution because of an approaching trial date
`
`guarantees that a stay will be denied, and thus becomes a self-fulfilling prophecy.
`
`Such circular reasoning cannot be the basis on which to deny an IPR.
`
`The “efficiency and integrity of the patent system” is best served when
`
`forum shopping for an IPR benefit is discouraged. See Paper 11 at 6, 15, and 16.
`
`Initial Trial Dates are Frequently Continued
`Trial dates are often moving targets. It is not uncommon to start with one
`
`trial date and end with a completely different one many months later. Indeed,
`
`more than 40% of cases which proceed to trial have their trial dates continued by
`
`3
`
`
`
`more than 4 months. Ex. 1035. Even if the Board considered only the Western
`
`District of Texas (WDTX) where the underlying case is pending, its median time-
`
`to-jury trial for patent cases is substantially the same as the nationwide median of
`
`over 2.5 years, which places trial after the PTAB’s FWD deadline. Exs. 1036
`
`(national); 1037 (WDTX). Moreover, looking only at trial dates ignores the fact
`
`that final judgment is rarely entered until months later after post-trial motions,
`
`making it even more likely that the PTAB will issue a FWD before the conclusion
`
`of district court proceedings. The initially scheduled trial date is thus a speculative
`
`basis on which to deny institution.
`
`That trial dates are uncertain and often in flux is reflected by the “apparent
`
`change in status” (viz. trial date assignment) which prompted the Board to request
`
`supplemental briefing. Paper 11 at 2. This alone makes Petitioner’s point that
`
`deciding § 314 issues on such a basis is unwise, and unfair to petitioners who
`
`cannot revisit institution when a trial is continued. And the Board can take judicial
`
`notice of the global COVID-19 pandemic which has disrupted trial schedules
`
`nationwide, including continuances of all WDTX civil trials (where the co-pending
`
`district court case is currently venued) scheduled before May 1, 2020. Ex. 1038.
`
`This will undoubtedly have a domino effect on subsequent trials. Moreover,
`
`COVID-19 has delayed depositions, service of subpoenas, source code reviews,
`
`and numerous other aspects of the co-pending district court case, making it likely
`
`4
`
`
`
`that trial will be continued even further.1 Exs. 1039, 1041.
`
`One need look no further than NHK where, after the Board’s institution
`
`decision, the court postponed trial multiple times by more than 8-months, belying
`
`the Board’s prediction that the trial would occur six months prior to the FWD. See
`
`Intri-Plex Techs. v. NHK Int’l Corp., 3:17-cv-01097 (N.D. Cal.) (Dkt. 173, 175).
`
`II.
`
`The NHK Factors Favor Institution
`As an initial matter, NHK did not hold that institution can be denied based
`
`solely on a trial date being before a FWD. NHK was primarily a § 325(d) analysis
`
`focused on the duplicative nature of the IPR grounds vis-à-vis the prosecution
`
`history, with the “state of the district court proceeding” under § 314(a) being
`
`merely an “additional factor” that supported denial. NHK at 19-20. Notably,
`
`Fintiv never raised a § 325(d) argument, nor could it have as there was practically
`
`no substantive prosecution and there are no other IPR petitions challenging
`
`the ’125 patent. Thus, the present proceeding is factually distinct from NHK.
`
`Regardless, even assuming that NHK held that the “advanced” state of a co-
`
`1 Only two fact depositions have been taken. Ex. 1039. With less than a month
`
`left in discovery, dozens of party depositions remain and Fintiv has noticed 14
`
`third-party depositions, not to mention more than eighty 30(b)(6) topics between
`
`the parties. Exs. 1039-1040. Before the Board requested § 314 briefing, the
`
`parties had raised the possibility of revising the case schedule. Ex. 1039.
`
`5
`
`
`
`pending litigation can itself justify denial of institution (it did not), the NHK factors
`
`still do not support denial in this case.
`
`Potential for a district court stay
`This factor is neutral or weighs in favor of institution. As there are no other
`
`co-pending actions (in the ITC or otherwise), a stay of the district court action
`
`would amount to a stay of all litigation outside of the PTAB on the ’125 patent.
`
`As numerous district courts have recognized, “Congress intended for district
`
`courts to be liberal” in granting stays pending PTAB proceedings. IOENGINE at
`
`10-11 (liberal stay policy applies to IPR and CBM proceedings); 157 Cong. Rec.
`
`S1363 (daily ed. Mar. 8, 2011) (Sen. Schumer) (Congress placed “a very heavy
`
`thumb on the scale in favor of a stay being granted”). This case is no exception.
`
`See, e.g., NFC Tech. LLC v. HTC Am., Inc., 2015 WL 1069111, at *7 (E.D. Tex.
`
`Mar. 11, 2015) (“[A]fter the PTAB has instituted review proceedings, the parallel
`
`district court litigation ordinarily should be stayed.”).2 There is no reason a stay
`
`2 Some courts have expressed reluctance to stay any litigation in view of an IPR.
`
`The likelihood that a particular judge or court will ultimately grant a stay should be
`
`afforded no weight in the § 314 analysis. Doing so improperly motivates patent
`
`owners to forum shop for venues that—contrary to Congressional intent—routinely
`
`deny stays, and petitioners should not be prejudiced in pursuing IPR based on the
`
`stay practices of the particular district or judge selected by the patent owner.
`
`6
`
`
`
`should be denied here and this factor favors institution.
`
`Proximity of the court’s trial date
`When Apple filed its petition, no trial date had been set. The district court
`
`subsequently set trial for November 16, 2020. See Ex. 2009. But, as noted in
`
`Section I, over 40% of trials are continued 4+ months and the trial here will likely
`
`be continued to near (or after) the May 2021 FWD date due to (1) conditions
`
`beyond anyone’s control (e.g., COVID-19 complications)3 and (2) circumstances
`
`unique to this case such as Fintiv’s delinquent document production and failure to
`
`timely make its witnesses available for deposition. Ex. 1039, 1043. Regardless of
`
`the precise trial date (which remains uncertain), Apple submits that the trial date
`
`should play little (if any) role in the Board’s decision here. See supra Section I.
`
`Investment in the parallel proceeding by the court and the parties
`Apart from the Markman proceedings, which Judge Albright conducts at an
`
`early stage, the district court has invested virtually no time in assessing the parties
`
`claims and defenses, including invalidity. No motion for preliminary injunction
`
`was filed, summary judgment is still months away, and it is unlikely the court will
`
`address any invalidity issues until trial.
`
`In contrast to NHK, where the petition was filed only 2-days before the
`
`3 Apple, its witnesses, both parties’ counsel, and Apple’s source code are near San
`
`Francisco and subject to a shelter-in-place order since March 16, 2020. Ex. 1042.
`
`7
`
`
`
`§ 315(b) deadline, Apple filed its IPR petition more than 2-months in advance. See
`
`NHK, Paper 1 (filed March 7, 2018) and Intri-Plex v. NHK, Case No. 17-cv-01097,
`
`Dkt. 8 (complaint served March 9, 2017) (N.D. Cal.). To ensure a FWD before
`
`trial (which had not been set), Apple would have had to file its IPR in April 2019.
`
`Apple had no pre-suit notice (Ex. 1034) and would need to have searched for prior
`
`art and drafted a petition in only 4 months, before Fintiv identified the asserted
`
`claims or disclosed its infringement contentions on May 20, 2019. Ex. 2023. But,
`
`as the Board has recognized, it is “reasonable for a petitioner to wait to file its
`
`petition until it learns which claims are being asserted against it.” Paper 11 at 11.4
`
`The bulk of the parties’ work also lies ahead (and any Apple efforts thus far
`
`should not be used to deny Apple’s IPR). See IOENGINE at *14. Fact discovery
`
`is ongoing and Fintiv only recently made its first substantial document production.
`
`Ex. 1043. Fintiv has taken only two depositions among the dozens it seeks from
`
`Apple and third-parties (and Apple has been unable to depose any Fintiv witness).
`
`Exs. 1039-1040. As noted above, the case schedule will need to be reset. Thus,
`
`this case should not be considered “advanced” and this factor favors institution.
`
`4 Further evincing the timeliness of Apple’s petition, Fintiv requested that Apple
`
`withdraw its petition and refile at a later date (Ex. 1044), and argued to the Board
`
`in a teleconference that Apple filed too early and should have waited until after the
`
`Markman order to avoid prejudicing Fintiv. See, e.g., Paper 6 at 3.
`
`8
`
`
`
`Overlap between issues in the petition and the parallel proceeding
`Apple’s district court invalidity contentions contain numerous prior art
`
`references—including various system art—that are not at issue in the IPR. Ex.
`
`1045. Thus, there is little overlap with the district court invalidity issues (and it
`
`would be inequitable and make little sense to incentivize defendants to withhold
`
`prior art from the district court just to increase the chance of IPR institution).
`
`Moreover, Apple has not decided whether it will pursue any of the IPR art in
`
`expert discovery or at trial. For this reason, Fintiv recently filed an amended
`
`complaint seeking a declaratory judgment of validity over the IPR art to force
`
`Apple to litigate the IPR art in district court. Ex. 1046. But this is not a cognizable
`
`cause of action and Apple has moved to dismiss it. Ex. 1047. Thus, there is no
`
`guarantee that any of the IPR art will be litigated in district court.
`
`Fintiv is also incorrect that the PTAB and district court apply “the same
`
`legal standards.” Paper 10 (POPR) at 24. The PTAB and district court
`
`indisputably examine invalidity through different lenses—the PTAB applies a
`
`lower burden of proof (preponderance of the evidence) than district court (clear
`
`and convincing evidence). 35 U.S.C. § 316(e). Thus, the invalidity “issues” are
`
`not the same and this factor does not support discretionary denial.
`
`While the same claims are challenged in both forums, petitioners like Apple
`
`should not be disadvantaged for respecting the Board’s resources by filing a
`
`9
`
`
`
`petition only after asserted claims are identified. See Paper 11 at 11. To hold
`
`otherwise incentives undesirable behavior (unnecessarily challenging numerous
`
`claims and/or filing multiple petitions). Indeed, the PTAB has cited this practice as
`
`a basis for denying institution. See, e.g., IPR2019-00885, Paper 21 at 15-16.
`
`Whether the petitioner and the defendant are the same party
`Here, the parties are the same in the IPR and district court proceeding. But
`
`this will almost always be the case. This factor should have little impact.
`
`Other circumstances impacting the Board’s exercise of discretion
`As discussed in Section I, other circumstances strongly favor institution. In
`
`particular, denying institution here will (1) negate the statutorily provided 1-year
`
`filing period, (2) encourage forum shopping, and (3) condition the institution of
`
`IPR on the timing of an oft-changed trial placeholder. No other parties have
`
`sought IPR of the ’125 patent. Mindful of the Board’s resources, Apple filed a
`
`strong single petition challenging only the asserted claims with one obviousness
`
`ground per claim. Fintiv’s POPR is particularly weak as demonstrated, for
`
`example, by its “secondary considerations” arguments. See Paper 10 at 63-67. As
`
`a representative example, Fintiv contends Apple copied the ’125 patent citing
`
`the ’125 patent itself (mistaking it for an Apple patent) and two other patents
`
`which, contrary to Fintiv’s assertion, do not cite the ’125 patent at all (one of
`
`which post-dates release of the accused Apple Pay technology). Id., 66; Ex. 1048.
`
`10
`
`
`
`Dated: March 27, 2020
`
`Respectfully submitted,
`
`/Travis Jensen/
`Travis Jensen, Reg. No. 60,087
`Orrick, Herrington & Sutcliffe LLP
`1000 Marsh Road
`Menlo Park, CA 94025-1015
`Phone: (650) 614-7400
`Fax: (650) 614-7401
`Email: tjensen@orrick.com
`
`Lead Counsel for Petitioner Apple Inc.
`
`11
`
`
`
`CERTIFICATE OF SERVICE
`The undersigned certifies, in accordance with 37 C.F.R. § 42.6(e), that service
`
`was made on the Patent Owner as detailed below.
`
`Date of Service
`
`March 27, 2020
`
`Manner of Service
`
`Electronic Mail
`
`Documents Served
`
`Apple Inc.’s Preliminary Reply
`
`Persons Served
`
`Patent Owner’s Counsel of Record
`Jonathan K. Waldrop (jwaldrop@kasowitz.com)
`Rodney R. Miller (rmiller@kasowitz.com)
`John W. Downing (jdowning@kasowitz.com)
`KASOWITZ BENSON TORRES LLP
`333 Twin Dolphin Drive, Suite 200
`Redwood Shores, CA 94065
`
`Additional Email addresses:
`Fintiv@kasowitz.com
`
`Dated: March 27, 2020
`
`Respectfully submitted,
`
`/Travis Jensen/
`Travis Jensen, Reg. No. 60,087
`Orrick, Herrington & Sutcliffe LLP
`1000 Marsh Road
`Menlo Park, CA 94025-1015
`Phone: (650) 614-7400
`Fax: (650) 614-7401
`Email: tjensen@orrick.com
`
`Lead Counsel for Petitioner Apple Inc.
`
`12
`
`